- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Dirinco B.V.
Total 1485 results
-
Bassett HealthcareGenentech, Inc.; Viroclinics Biosciences B.V.Recruiting
-
University Medical Center GroningenJanssen-Cilag B.V.CompletedHidradenitis SuppurativaNetherlands
-
Pharming Technologies B.V.US Hereditary Angioedema AssociationCompleted
-
Radboud University Medical CenterGoodlife Fertility B.V.Active, not recruitingMale SubfertilityNetherlands
-
Kuros Biosurgery AGAvania; Kuros BioSciences B.V.Active, not recruitingDegenerative Disc Disease | Spinal FusionUnited States
-
Medical University of WarsawWinclove Probiotics B.V.CompletedAntibiotic-associated DiarrheaPoland, Netherlands
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive Bladder | Pharmacokinetics of Mirabegron | Neurogenic Detrusor OveractivityBelgium, Denmark, Norway, Poland, Serbia
-
Astellas Pharma Europe B.V.CompletedHealthy VolunteersUnited States
-
University Hospital, Gentofte, CopenhagenMCM Vaccines B.V.CompletedThe Impact of Lixisenatide on Postprandial Glucose Tolerance in Pancreatectomised Subjects (Px-Lixi)Diabetes After Total Pancreatectomy
-
Astellas Pharma Europe B.V.CompletedInterstitial Cystitis | Bladder Pain SyndromeSpain, Russian Federation, Belgium, Czechia, Germany, Hungary, Latvia, Netherlands, Poland, United Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Type 2 Diabetes Mellitus (T2DM) | Chronic Kidney Disease (CKD) | Pharmacokinetics of ASP8232 | Pharmacodynamics of ASP8232Bulgaria, Moldova, Republic of, Romania
-
Astellas Pharma Europe B.V.CompletedDiabetes Mellitus | Diabetic Macular EdemaUnited States
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic DiseasesBelgium, Russian Federation, Korea, Republic of, United States, Germany, Spain, Australia, Bulgaria, Canada, Czechia, Denmark, Estonia, Finland, Hungary, Italy, Latvia, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, ... and more
-
Astellas Pharma Europe B.V.CompletedLower Urinary Tract Symptoms | Benign Prostatic HyperplasiaBelgium, Italy, France, Austria, United Kingdom, Netherlands, Poland, Slovakia, Belarus, Germany, Czechia
-
Astellas Pharma Europe B.V.CompletedType 2 Diabetes MellitusGermany
-
Astellas Pharma Europe B.V.CompletedLower Urinary Tract Symptoms | Benign Prostatic HyperplasiaBelgium, Italy, France, Austria, United Kingdom, Netherlands, Hungary, Russian Federation, Poland, Slovakia, Czech Republic, Belarus, Germany
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, Czech Republic, Germany, Spain, Sweden, United Kingdom
-
Astellas Pharma Europe B.V.CompletedAdvanced Prostate CarcinomaRussian Federation
-
Astellas Pharma Europe B.V.CompletedHealthy VolunteersUnited Kingdom
-
Astellas Pharma International B.V.TerminatedChronic Lymphocytic Leukaemia (CLL) | Indolent Non Hodgkin's Lymphoma (iNHL)Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates
-
Astellas Pharma Europe B.V.CompletedVenous Thromboembolism | Arthroplasty, Replacement, HipDenmark, Spain, United States, Austria, Colombia, Russian Federation, India, Italy, United Kingdom, Germany, Hungary, Estonia, Romania, South Africa, Israel, Poland, Sweden, Canada, Australia, Lithuania, Ukraine, Latvia, Finland, Brazil, Slovak... and more
-
Astellas Pharma Europe B.V.CompletedHealthy SubjectsUnited Kingdom
-
Astellas Pharma Europe B.V.CompletedPharmacokinetics of ASP1707 | Pharmacodynamics of ASP1707France
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive Bladder | Urinary Incontinence | Urge IncontinenceFrance, Belgium, Spain, Turkey, Australia, Russian Federation, Hungary, Italy, Netherlands, Poland, Czech Republic
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Drug-Drug Interaction (DDI)France
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | EC905United Kingdom
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics of ASP3652United Kingdom
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive BladderPoland, United Kingdom, Germany, Spain, Netherlands, Belgium, Czech Republic, Italy, Norway, Hungary, Sweden, Denmark, Greece, France, Russian Federation
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics of YM178Netherlands
-
Astellas Pharma Europe B.V.CompletedA Study to Find Out How YM150 is Absorbed Into and Eliminated From the Body in Healthy Male SubjectsHealthy Male Subjects | PharmacokineticsNetherlands
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedThromboembolismItaly, Spain, Sweden, Austria, Denmark, Russian Federation, Poland, Bosnia and Herzegovina, Serbia, Norway, Latvia, Finland, Lithuania, Czech Republic, Germany, Slovakia, Greece
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | Pharmacodynamics | SafetyNetherlands
-
Catharina Ziekenhuis EindhovenAlloksys Life Sciences B.V.CompletedCoronary Artery Disease | Endotoxin-mediated Complications From Cardiopulmonary Bypass SurgeryNetherlands
-
Kocaeli Derince Education and Research HospitalNot yet recruiting
-
Kocaeli Derince Education and Research HospitalActive, not recruitingBariatric Surgery Candidate | Ultrasound Therapy; Complications | Postoperative AtelectasisTurkey
-
Kocaeli Derince Education and Research HospitalCompleted
-
Kocaeli Derince Education and Research HospitalCompleted
-
Kocaeli Derince Education and Research HospitalUnknownAtherosclerosis | Non-diabetic Chronic Kidney DiseaseTurkey
-
NHS National Waiting Times Centre BoardBoston Scientific Corporation; Diagram B.V.; Venn Life Sciences; Cardialysis B.V.UnknownCoronary Artery Disease
-
VieCuri Medical CentreSiemens Healthineers Nederland B.V.RecruitingMyocardial Infarction | Myocardial Ischemia | Chest Pain | Acute Coronary Syndrome | Heart AttackNetherlands
-
Laboratoires VivacyAvania B.V.; Canfield Scientific Inc.Active, not recruitingAging | Aesthetics | Volume Deficiency in the Mid-FaceFrance
-
Astellas Pharma Europe B.V.CompletedNeurogenic Detrusor OveractivityBelgium, Croatia, Turkey, Australia, Denmark, Israel, Jordan, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Norway, Philippines, Poland, Romania, Serbia, Slovakia, Taiwan
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Neurogenic Detrusor OveractivityDenmark, Poland
-
Astellas Pharma Europe B.V.CompletedOsteoarthritis of the Knee | Chronic Lower Back PainBelgium, Czechia, Germany, Hungary, Spain, United Kingdom
-
MCM Vaccines B.V.Merck Sharp & Dohme LLCCompletedVirus Diseases | Bacterial Infections
-
Astellas Pharma Europe B.V.CompletedEndometriosisBelgium, Bulgaria, Germany, Hungary, Japan, Poland, Romania, Ukraine, United Kingdom
-
Astellas Pharma Europe B.V.CompletedPediatric | Neurogenic Detrusor OveractivityUnited States, Belgium, Korea, Republic of, Philippines, Poland, United Kingdom
-
Merck Sharp & Dohme LLCMCM Vaccines B.V.CompletedVirus Diseases | Bacterial Infections
-
Merck Sharp & Dohme LLCMCM Vaccines B.V.CompletedVirus Diseases | Bacterial Infections
-
Astellas Pharma Europe B.V.CompletedType 2 Diabetes | Chronic Kidney DiseaseSpain, Czechia, Denmark, Germany, Hungary, Italy, Netherlands, Poland, United Kingdom